Form 4 for IRD Opus Genetics, Inc.
Accepted 2026-01-26 00:00:00 ET · period of report 2026-01-22 · accession 0000905148-26-000354 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-26 | 2026-01-22 | IRD | Gagnon Robert E. | CFO | A - Grant | $0.00 | +400.0K | 600.0K | +200% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-22 | A | A | 400,000 | $0.00 | 600,000 | D | — | — | (F1) Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service. |